when is semaglutide off patent Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants As the patent for semaglutide,

Together, these forms of inositol act as natural insulin sensitizers, making it easier to reach a healthy weight and feel more energized

GLP-1 medications are prescription drugs that require evaluation by a licensed clinician

J Biol Chem 267(11):74027405 Schirra J, Sturm K, Leicht P, Arnold R, Goke B, Katschinski M (1998) Exendin(939)amide is an antagonist of glucagon-like peptide-1(736)amide in humans

While these companies are run by sophisticated teams, the institutional momentum seems to be forcing sweet portfolios into one of two distinct, and dangerous, camps

The Power of Wegovy For weight management in certain individuals

Whats shifted the market is the focus on a weight loss drug that otherwise healthy folks will spend thousands of dollars on for weight loss purposes, ultimately, as TIME writes, exposing the cracks in the body positivity movement. The birth of these drugs induced an ongoing shortage in 2022, primarily because of its miracle drug qualities